S-1 · primary offering
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
CRIS$0.6855+3.71%
Curis Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$4.58M
Float & O/S:
Inst Own:
DilutionScan read 38 of CURIS INC's SEC filings and found 16 warrant series, 1 convertible, 1 ATM program, 5 shelf registrations, 2 S-1 registrations and 3 completed offerings on file for CRIS. The latest dilution event on file is a warrant issuance on Oct 19, 2026. Analysis updated Oct 24, 2026.
Signal8 Summary
CRIS
Imminent cash shortfall and reverse split
Snapshot
Curis is a clinical-stage biotechnology company burning cash at an unsustainable rate. With $27.2M in annual free cash flow outflows and only $5.1M in the bank, the company has roughly a two-month cash runway.
What's Happening Right Now
- : Curis priced a $5.6M public offering to raise capital, a necessary step given its short cash runway.
- : The company dosed the first five patients in its TakeAim CLL study, with initial data expected in December 2026.
- : Updated data for emavusertib showed a 100% response rate in BTKi-naive PCNSL patients and increased guidance for year-end CLL data.
- : The 1-for-20 reverse stock split approved by shareholders became effective to regain compliance with Nasdaq listing rules.
- : Curis solicited shareholder approval for a reverse split after receiving a Nasdaq delisting notice for trading below $1.00.
Raise routes on file: active ATM + effective shelf + effective S-1 · latest dilution event 15 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Oct 19, 2026 · Warrant Issuance
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Completed
S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
October 2024 Common Warrants
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
March 2025 Common Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
March 2025 Pre-Funded Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
July 2025 Common Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
July 2025 Pre-Funded Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
January 2026 Series A Common Warrants
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
ATM program
Issued 2024
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
PIPE
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Public offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your CRIS trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
